Literature DB >> 22267333

Aortic stiffness is increased in polymyalgia rheumatica and improves after steroid treatment.

Giuseppe Schillaci1, Elena Bartoloni, Giacomo Pucci, Matteo Pirro, Laura Settimi, Alessia Alunno, Roberto Gerli, Elmo Mannarino.   

Abstract

BACKGROUND: Inflammatory rheumatic diseases have been associated with increased cardiovascular risk and arterial stiffness. Polymyalgia rheumatica (PMR), a disease which affects primarily older people, is characterised by a systemic inflammatory response but little is known about aortic involvement in PMR. A study was undertaken to investigate whether aortic stiffness is increased in PMR and whether it improves after steroid treatment.
METHODS: Thirty-nine patients with PMR (age 72 ± 8 years, 44% men, blood pressure (BP) 134/75 ± 16/9 mm Hg) and 39 age-, sex- and BP-matched control subjects underwent aortic pulse wave velocity (PWV) determination. Aortic augmentation as a measure of the impact of the reflection wave on central haemodynamics was also measured and corrected for heart rate. Twenty-nine of the patients were re-examined after 4 weeks of treatment with prednisone at a dose of 15 mg/day.
RESULTS: Aortic PWV was higher in patients with PMR than in control subjects (12.4 ± 4 vs 10.2 ± 2 m/s, p<0.01). Treatment was followed by a reduction in heart rate (from 78 ± 12 to 70 ± 10 beats/min, p<0.001) and no significant change in BP. Aortic PWV decreased after prednisone treatment (from 11.8 ± 3 to 10.5 ± 3 m/s, p=0.015), and the difference was independent of BP and heart rate changes. The change in aortic PWV had a direct correlation with percentage change in plasma C reactive protein (r=0.40, p=0.037). Treatment was also associated with a significant reduction in aortic augmentation index (from 34 ± 7% to 29 ± 8%, p=0.012).
CONCLUSIONS: Polymyalgia rheumatica is associated with increased aortic stiffness which may improve upon reduction of systemic inflammation induced by treatment with glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22267333     DOI: 10.1136/annrheumdis-2011-200751

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

1.  Myocardial inflammation in polymyalgia rheumatica assessed using cardiac magnetic resonance imaging.

Authors:  Sophie Mavrogeni; Konstantinos Bratis; Clio P Mavragani
Journal:  Exp Clin Cardiol       Date:  2013

2.  Prenatal metyrapone treatment modulates neonatal cerebrovascular structure, function, and vulnerability to mild hypoxic-ischemic injury.

Authors:  P Naomi Franco; Lara M Durrant; Desirelys Carreon; Elizabeth Haddad; Adam Vergara; Catherine Cascavita; Andre Obenaus; William J Pearce
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-02       Impact factor: 3.619

Review 3.  The Gut Microbiota and Vascular Aging: A State-of-the-Art and Systematic Review of the Literature.

Authors:  Davide Agnoletti; Federica Piani; Arrigo F G Cicero; Claudio Borghi
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

4.  The effects of treatment in patients with childhood asthma on the elastic properties of the aorta.

Authors:  Osman Bektaş; Zeki Yüksel Günaydin; Ahmet Karagöz; Recep Akgedik; Adil Bayramoğlu; Ahmet Kaya
Journal:  Cardiovasc J Afr       Date:  2017 May/Jun       Impact factor: 1.167

5.  Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.

Authors:  Amir Emamifar; Søren Hess; Oke Gerke; Anne Pernille Hermann; Helle Laustrup; Per Syrak Hansen; Peter Thye-Rønn; Niels Marcussen; Frank Svendstrup; Rannveig Gildberg-Mortensen; Jacob Christian Bang; Ziba Ahangarani Farahani; Stavros Chrysidis; Pia Toftegaard; Rikke Asmussen Andreasen; Sebastian le Greves; Hanne Randi Andersen; Rudolf Nezlo Olsen; Inger Marie Jensen Hansen
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

6.  An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica.

Authors:  Rossana Scrivo; Valeria Silvestri; Francesco Ciciarello; Paola Sessa; Iolanda Rutigliano; Cristina Sestili; Giuseppe La Torre; Cristiana Barbati; Alessio Altobelli; Cristiano Alessandri; Fulvia Ceccarelli; Manuela Di Franco; Roberta Priori; Valeria Riccieri; Antonio Sili Scavalli; Francesca Romana Spinelli; Luciano Agati; Francesco Fedele; Bruno Gossetti; Fabrizio Conti; Guido Valesini
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

Review 7.  Subclinical Atherosclerosis in Primary Sjögren's Syndrome: Does Inflammation Matter?

Authors:  Elena Bartoloni; Alessia Alunno; Giacomo Cafaro; Valentina Valentini; Onelia Bistoni; Angelo Francesco Bonifacio; Roberto Gerli
Journal:  Front Immunol       Date:  2019-04-17       Impact factor: 7.561

8.  Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  Amir Emamifar; Torkell Ellingsen; Anne Pernille Hermann; Søren Hess; Oke Gerke; Ziba Ahangarani Farahani; Per Syrak Hansen; Inger Marie Jensen Hansen; Peter Thye-Rønn
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

Review 9.  Arterial stiffness and cardiovascular therapy.

Authors:  Miodrag Janić; Mojca Lunder; Mišo Sabovič
Journal:  Biomed Res Int       Date:  2014-08-07       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.